about
Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in CambodiaArtemisinin Resistance in Plasmodium falciparum MalariaA molecular marker of artemisinin-resistant Plasmodium falciparum malariaGenetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association studyGenetic architecture of artemisinin-resistant Plasmodium falciparumOrigin and evolution of sulfadoxine resistant Plasmodium falciparumHigh-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool.Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis.Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern CambodiaIgG autoantibody to brain beta tubulin III associated with cytokine cluster-II discriminate cerebral malaria in central India.Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia.Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007Countrywide survey shows very high prevalence of Plasmodium falciparum multilocus resistance genotypes in Cambodia.Drug resistance. Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance.Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia.pfcrt polymorphism and chloroquine resistance in Plasmodium falciparum strains isolated in CambodiaMultiple genetic backgrounds of the amplified Plasmodium falciparum multidrug resistance (pfmdr1) gene and selective sweep of 184F mutation in CambodiaDecreasing pfmdr1 copy number suggests that Plasmodium falciparum in Western Cambodia is regaining in vitro susceptibility to mefloquineLarge-scale malaria survey in Cambodia: novel insights on species distribution and risk factors.Using CF11 cellulose columns to inexpensively and effectively remove human DNA from Plasmodium falciparum-infected whole blood samplesDihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study.Towards high-throughput molecular detection of Plasmodium: new approaches and molecular markersArtemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study.Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studiesMultiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia.Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in western, northern, and eastern Cambodia, 2011-2012: association with molecular markers.Therapeutic efficacy of fixed dose artesunate-mefloquine for the treatment of acute, uncomplicated Plasmodium falciparum malaria in Kampong Speu, Cambodia.Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration.FlexiChip package: an universal microarray with a dedicated analysis software for high-thoughput SNPs detection linked to anti-malarial drug resistance.Host immunity to Plasmodium falciparum and the assessment of emerging artemisinin resistance in a multinational cohort.Population Pharmacokinetic and Pharmacodynamic Modeling of Artemisinin Resistance in Southeast Asia.In vitro monitoring of Plasmodium falciparum susceptibility to artesunate, mefloquine, quinine and chloroquine in Cambodia: 2001-2002.Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6.Importance of protection of antimalarial combination therapies.Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia.Plasmepsin II-III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum.
P50
Q21034146-7C5E56B1-4784-4B64-B3D7-0061AFFDEB55Q22061852-C73C53D2-C4F4-4727-AEFA-EBA14F431758Q22061872-500CA44D-50D3-42E8-A30E-02307341032BQ27861941-5F3ADD52-BC33-4689-ACCB-241D970BD70EQ28030935-B6AADE54-2E0E-4F6C-BE91-C50FE1955D7EQ28473479-D661D57D-94EE-46B6-B149-06B44D991887Q30619647-DB8B1586-89CA-4148-A5CE-2999560C8B97Q30995133-0922755B-840D-43CF-B440-791798069E01Q33399259-AB085B61-4C0F-4937-BC9D-58E4E4B0FC7AQ33518569-830DD5AB-E223-4678-87F3-6634B4895DB5Q33668137-456E36A0-BD89-4AA4-9C8C-BB6CB5D1D1A3Q33826378-739842B7-7414-4FB0-8519-45A2FE9AAD63Q33938016-C1275902-0E42-4B1A-AA21-0CCA5A1D6183Q34453540-9FECB7E0-CE4B-4405-B20E-72C56E961003Q34560158-B20DDC07-3774-46B0-9BCA-BAF164FAE8E9Q34723972-536095A2-149F-4603-B7F8-0BFD75A3C73DQ34986023-9D6E2F9D-A44D-4611-B033-0D6BD151FE1AQ35385674-658B5703-D359-4CAB-B981-3B99405B4A38Q35741357-47C82302-76C7-4CBF-8B30-EC1139B796EAQ35808996-3245F0AF-0B3F-4838-A301-70C8772931EAQ36689509-DC348B13-D8D4-4127-B096-1240ABEDFAAEQ37203050-8601CA1B-1E3F-483D-AFC3-C1B7F15D6FB3Q37205700-8FD23C0F-79B4-431D-B7E7-9983D3A64E1AQ37240876-5615ABDC-C406-4B87-BC2C-B1A7D8E4B271Q37253966-F2EDD325-D216-4153-B5AA-435973354808Q37263344-84762AE3-0983-4C07-8956-758322BB2E70Q37366389-EAE0CB73-6D3C-42E7-BE1A-1F15BF55BDE8Q37402952-D5F0A9D1-2490-4A74-8CA8-B80B954C56CFQ37405832-05394CE3-8BF4-4289-8038-3C01AD185D1EQ38882700-76A3259E-248F-4A97-862C-6B4D7B8B4650Q40051806-F92E51C9-CF91-44DC-AB84-8DFA2B51C7EAQ41913057-F6FE3157-12DC-4094-91E5-14BEE48A9B6DQ46833947-E3D9ADBF-5488-4CA1-91A6-E821E7ECB603Q47998914-CAFEF8C3-F573-46E3-9204-A27BB3ACD989Q48037074-02961972-51F2-4399-9DE2-A618506F29B2Q55001227-83174DC1-AA9B-4053-A19A-EE064F0DFBAB
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Pharath Lim
@ast
Pharath Lim
@en
Pharath Lim
@es
Pharath Lim
@nl
Pharath Lim
@sl
type
label
Pharath Lim
@ast
Pharath Lim
@en
Pharath Lim
@es
Pharath Lim
@nl
Pharath Lim
@sl
prefLabel
Pharath Lim
@ast
Pharath Lim
@en
Pharath Lim
@es
Pharath Lim
@nl
Pharath Lim
@sl
P106
P1153
7202592301
P21
P31
P496
0000-0002-1012-2461
P569
2000-01-01T00:00:00Z